203 related articles for article (PubMed ID: 36709412)
1. In vitro characterization on the role of APOE polymorphism in human hippocampal neurogenesis.
Lee H; Price J; Srivastava DP; Thuret S
Hippocampus; 2023 Apr; 33(4):322-346. PubMed ID: 36709412
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
3. APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes.
Zhao J; Davis MD; Martens YA; Shinohara M; Graff-Radford NR; Younkin SG; Wszolek ZK; Kanekiyo T; Bu G
Hum Mol Genet; 2017 Jul; 26(14):2690-2700. PubMed ID: 28444230
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cells derived from one 70-years-old male donor with the APOE-ε4/ε4 alleles.
Wang J; Liu X; Du X; Ma Z; Liu B; Guo R; Feng B; Ma J; Cui H
Stem Cell Res; 2021 May; 53():102395. PubMed ID: 34088020
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
[TBL] [Abstract][Full Text] [Related]
6. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
7. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
8. Integration-free induced pluripotent stem cell line derived from a 62-years-old male donor with APOE-epsilon4/epsilon4 alleles.
Guo R; Liu X; Zhang J; Ma X; Gou D; Ma Z; Wang L; Ma J; Cui H
Stem Cell Res; 2022 May; 61():102746. PubMed ID: 35305470
[TBL] [Abstract][Full Text] [Related]
9. Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.
Panitch R; Hu J; Xia W; Bennett DA; Stein TD; Farrer LA; Jun GR
Alzheimers Res Ther; 2022 Feb; 14(1):30. PubMed ID: 35139885
[TBL] [Abstract][Full Text] [Related]
10. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
[TBL] [Abstract][Full Text] [Related]
11. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E gene polymorphism in the Mongolian population.
Svobodová H; Kucera F; Stulc T; Vrablík M; Amartuvshin B; Altannavch Ts; Ceska R
Folia Biol (Praha); 2007; 53(4):138-42. PubMed ID: 17706019
[TBL] [Abstract][Full Text] [Related]
13. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
14. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
[TBL] [Abstract][Full Text] [Related]
15. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.
Souza DR; de Godoy MR; Hotta J; Tajara EH; Brandão AC; Pinheiro Júnior S; Tognola WA; dos Santos JE
Braz J Med Biol Res; 2003 Jul; 36(7):919-23. PubMed ID: 12845379
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene in physiological and pathological aging.
Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
[TBL] [Abstract][Full Text] [Related]
19. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
